People with pockets of fat hidden within their muscles have a higher risk of dying from heart-related health problems, ...

For people with atrial fibrillation (Afib), investigational abelacimab proved to be a potent dual factor XI/XIa inhibitor with much lower safety risks compared with a direct oral anticoagulant (DOAC), ...

Researchers evaluated a drug that represents a new class of anticoagulants known as Factor XI inhibitors for treating patients with atrial fibrillation as part of the AZALEA-TIMI 71 Study. The trial ...

Intramuscular fat, contained within muscle tissue, increases the risk of serious heart disease, regardless of other risk factors, a new study suggests.

Dr. Saef Izzy, Associate Professor of Neurology at Harvard Medical School, commented, “Treatment with nasal anti-CD3 not only dampened microglial activation but also led to marked improvements in ...

Glucarpidase significantly improved kidney function for patients who developed acute kidney injury from high-dose ...

Xenon gas, currently used in medicine as an anesthetic and neuroprotective agent for treating brain injuries, showed potential in protecting the brain in studies.

A Medscape survey found that a strong majority of physicians believe high-risk patients should have easier access to new weight loss drugs.

Subcutaneous injection of abelacimab results in lower levels of free factor XI and significantly fewer bleeding even ...

Researchers uncover promising evidence that xenon gas, commonly used in anesthesia, may help reduce brain deterioration and ...

The researchers found that for every one per cent increase in muscle fat, there was an increase in coronary microvascular dysfunction and serious heart disease. Read on to know more.

The grant funding comes as President-elect Donald Trump prepares to reenter the White House, a political shift that advocates worry will have negative consequences for the reproductive healthcare ...